Neurotransmitter Support with L-Carnitine
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 8 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 16 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Molybdène: up to 180 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 300 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 200 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Sélénium: up to 300 µg a day according to the dosing instructions published by Health Canada, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (255 µg a day). The EFSA reference covers total daily intake, from food and supplements.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 25 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 200 mg | Not calculated |
| Potassium Source : Citrate de potassium | 17 mg | 68,000 µg |
| Manganèse Source : Citrate de manganèse (II) | 2 mg | 8,000 µg |
| L-Tyrosine Source : L-Tyrosine | 50 mg | Not calculated |
| Zinc Source : Picolinate de zinc | 4 mg | 16,000 µg |
| Molybdène Source : Citrate de molybdène | 45 mcg | 180 µg |
| Sélénium Source : Sélénate de sodium | 75 mcg | 300 µg |
| Folate Source : L-5-methyltetrahydrofolate | 250 mcg | Not calculated |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Acide R-alpha lipoïque | 100 mg | Not calculated |
| Acide d-pantothénique Source : D-Pantothénate de calcium | 25 mg | Not calculated |
| Chrome Source : Picolinate de chrome | 50 mcg | 200 µg |
| L-thréonine Source : L-thréonine | 100 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 250 mcg | 1,000 µg |
| Cuivre Source : Citrate cuivrique | 45 mcg | 180 µg |
Non-medicinal ingredients
Hypromellose, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. An antioxidant for the maintenance of good health. A factor in the maintenance of good health. A vitamin/mineral supplement, multi-vitamin, multi-mineral or multi-vitamin/mineral. Helps to prevent zinc, niacin, pantothenic acid, molybdenum, vitamin B6, manganese, selenium, chromium, folate and vitamin B12 deficiencies. Provides support for healthy glucose metabolism. Helps in tissue formation. Helps in normal growth and development. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain healthy skin. Helps to maintain immune function. Helps in the development and maintenance of bones. Helps to form red blood cells. Helps to produce and repair connective tissue. Helps in connective tissue formation. Source of precursors involved in production of neurotransmitters.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Doctor's Choice Neurotransmitter Support with L-Carnitine, Life Choice Neurotransmitter Support with L-Carnitine, Your Natural Choice Neurotransmitter Support with L-Carnitine
- Licence holder
- Life Choice Ltd.
- NPN or DIN-HM
- 80042688
- Status
- Active licence
- Licence date
- 6 June 2013
- Revision date
- 27 September 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80042688
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Neurotransmitter Support with L-Carnitine”, https://compoatlas.com/en/supplements/canada/80042688-neurotransmitter-support-with-l-carnitine, updated 27 September 2016.